WO2007057490A3 - Immunogenic polypeptides of presenilin-1-associated protein (psap), methods of obtaining antibodies and use of same - Google Patents
Immunogenic polypeptides of presenilin-1-associated protein (psap), methods of obtaining antibodies and use of same Download PDFInfo
- Publication number
- WO2007057490A3 WO2007057490A3 PCT/ES2006/000636 ES2006000636W WO2007057490A3 WO 2007057490 A3 WO2007057490 A3 WO 2007057490A3 ES 2006000636 W ES2006000636 W ES 2006000636W WO 2007057490 A3 WO2007057490 A3 WO 2007057490A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- psap
- methods
- same
- presenilin
- associated protein
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4702—Regulators; Modulating activity
- C07K14/4703—Inhibitors; Suppressors
Abstract
The invention relates to polynucleotides which code for immunogenic peptides that can produce antibodies which interact with membrane protein PSAP. The invention also relates to methods of obtaining the aforementioned antibodies and to uses of same.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ES200502840A ES2319477B1 (en) | 2005-11-18 | 2005-11-18 | PSAP ISOFORMS, ANTIGENIC DETERMINANTS, METHOD OF OBTAINING ANTIBODIES AND USES OF THE SAME. |
ESP200502840 | 2005-11-18 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2007057490A2 WO2007057490A2 (en) | 2007-05-24 |
WO2007057490A3 true WO2007057490A3 (en) | 2007-07-05 |
Family
ID=38049004
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/ES2006/000636 WO2007057490A2 (en) | 2005-11-18 | 2006-11-16 | Immunogenic polypeptides of presenilin-1-associated protein (psap), methods of obtaining antibodies and use of same |
Country Status (2)
Country | Link |
---|---|
ES (1) | ES2319477B1 (en) |
WO (1) | WO2007057490A2 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2319602B1 (en) * | 2007-07-13 | 2010-02-16 | Univ Zaragoza | POLYPETIDES DERIVED FROM THE PSAP PROTEIN (PSESENILIN 1-ASSOCIATED PROTEIN) ABLE TO INDUCE APOPTOSIS AND USES THEMSELVES. |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2000004150A1 (en) * | 1998-07-16 | 2000-01-27 | Incyte Pharmaceuticals, Inc. | Human presenilin-associated protein |
WO2004078112A2 (en) * | 2003-03-07 | 2004-09-16 | Asahi Kasei Pharma Corporation | Apoptosis inducing gene |
-
2005
- 2005-11-18 ES ES200502840A patent/ES2319477B1/en active Active
-
2006
- 2006-11-16 WO PCT/ES2006/000636 patent/WO2007057490A2/en active Application Filing
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2000004150A1 (en) * | 1998-07-16 | 2000-01-27 | Incyte Pharmaceuticals, Inc. | Human presenilin-associated protein |
WO2004078112A2 (en) * | 2003-03-07 | 2004-09-16 | Asahi Kasei Pharma Corporation | Apoptosis inducing gene |
Non-Patent Citations (2)
Title |
---|
XU X. ET AL.: "Identification of a novel PSD-95/Dlg/ZO-1 (PDZ)-like protein interacting with the C terminus of presenilin-1", THE JOURNAL OF BIOLOGICAL CHEMISTRY, vol. 274, no. 46, 12 November 1999 (1999-11-12), pages 32543 - 32546, XP000879633 * |
XU X. ET AL.: "The novel presenilin-1 associated protein is a proapoptopic mitochondrial protein", THE JOURNAL OF BIOLOGICAL CHEMISTRY, vol. 277, no. 50, 13 December 2002 (2002-12-13), pages 48913 - 48922, XP003015413 * |
Also Published As
Publication number | Publication date |
---|---|
WO2007057490A2 (en) | 2007-05-24 |
ES2319477A1 (en) | 2009-05-07 |
ES2319477B1 (en) | 2010-02-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2006127757A3 (en) | Interferon-igg fusion | |
WO2006105338A3 (en) | Fc VARIANTS WITH OPTIMIZED PROPERTIES | |
WO2004078778A3 (en) | PEPTIDES THAT SPECIFICALLY BIND HGF RECEPTOR (cMet) AND USES THEREOF | |
WO2006083301A3 (en) | Immunogenic compositions comprising hmgb1 polypeptides | |
WO2007041635A3 (en) | Fc variants with optimized fc receptor binding properties | |
WO2004099249A3 (en) | Optimized fc variants and methods for their generation | |
WO2006066024A8 (en) | Pancreatic polypeptide family motifs, polypeptides and methods comprising the same | |
WO2007133290A3 (en) | Anti-ox40l antibodies and methods using same | |
WO2006138343A3 (en) | Compositions comprising receptor - associated protein (rap) variants specific for lrp2 and uses thereof | |
WO2004080148A3 (en) | Novel nucleic acids and polypeptides | |
WO2007047303A3 (en) | Pegylated glutenase polypeptides | |
WO2008054821A3 (en) | Mutant hydrolase proteins with enhanced kinetics and functional expression | |
WO2006091421A3 (en) | Peptides for detection of antibody to ehrlichia ewingii | |
WO2005069854A3 (en) | Methods and materials relating to novel c1q domain-containing polypeptides and polynucleotides | |
WO2007008583A3 (en) | Improved protein expression comparison assay results and applications | |
WO2008086035A3 (en) | Split mutant hydrolase fusion reporter and uses thereof | |
HUE038753T2 (en) | Peptides derived from human BPLP protein, polynucleotides coding for said peptides and antibodies directed against said peptides | |
WO2004087874A3 (en) | Novel nucleic acids and polypeptides | |
WO2010051056A3 (en) | ANTI-FcεRI POLYPEPTIDES AND THEIR USES | |
WO2007045019A3 (en) | Polyoleosins | |
WO2007063129A3 (en) | Insolation of peptides , polypeptides and proteins | |
WO2006063028A3 (en) | Immunostimulatory compositions and uses thereof | |
WO2005049806A3 (en) | Novel nucleic acids and polypeptides | |
WO2006100430A3 (en) | Polypeptides | |
WO2008005470A3 (en) | Polypeptides that bind membrane proteins |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
DPE1 | Request for preliminary examination filed after expiration of 19th month from priority date (pct application filed from 20040101) | ||
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 06847051 Country of ref document: EP Kind code of ref document: A2 |